Dr. Berg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
201 S 68th St Pl
Ste. 200
Lincoln, NE 68510Phone+1 402-420-7000Fax+1 402-420-6969- Is this information wrong?
Education & Training
University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1983 - 1985
University of North DakotaResidency, Internal Medicine, 1980 - 1983- University of North Dakota School of Medicine and Health SciencesClass of 1980
Certifications & Licensure
IA State Medical License 1984 - Present
ND State Medical License Current
NE State Medical License 1983 - 2024
KS State Medical License 1992 - 2016
MN State Medical License 1981 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer Start of enrollment: 2007 Sep 01
- Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma Start of enrollment: 2010 Jun 22
- A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma Start of enrollment: 2012 Jun 03
Publications & Presentations
PubMed
- 120 citationsThe use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trialLisa A. Kottschade, Jeff A. Sloan, Miroslaw Mazurczak, David B. Johnson, Bronagh P. Murphy, Kendrith M. Rowland, De Anne A. Smith, Alan R. Berg, Philip J. Stella, Char...> ;Supportive Care in Cancer. 2011 Nov 1
- The use of vitamin E for prevention of chemotherapy-induced peripheral neuropathy: A phase III double-blind, placebo controlled study-N05C31.Kottschade LA, Sloan JA, Mazurczak MA, Johnson DB, Murphy B, Rowland KM, Smith DA, Berg A, Stella PJ, Loprinzi CL> ;J. Clin. Oncol.. 2009-05-20
- 58 citationsEvaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial.Charles L. Loprinzi, Ralph Levitt, Debra L. Barton, Jeff A. Sloan, Pamela J. Atherton, Denise J. Smith, Shaker R. Dakhil, Dennis F. Moore, James E. Krook, Kendrith M. ...> ;Cancer. 2005 Jul 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Bryan Medical CenterLincoln, Nebraska- CHI Health St ElizabethLincoln, Nebraska
- Jefferson Community Health and LifeFairbury, Nebraska
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
